Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
7.59
+0.07 (0.93%)
At close: Feb 21, 2025, 4:00 PM
7.70
+0.11 (1.45%)
After-hours: Feb 21, 2025, 7:57 PM EST
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $181.43 million as of February 21, 2025. Its market cap has increased by 43.44% in one year.
Market Cap
181.43M
Enterprise Value
164.27M
1-Year Change
43.44%
Ranking
Category
Stock Price
$7.59
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $181.43M, an increase of 212.79%. That is a compound annual growth rate of 45.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 181.43M | 73.58% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |